期刊
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
卷 33, 期 1, 页码 95-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2012.10.006
关键词
Chronic obstructive pulmonary disease; Exacerbation; Respiratory viruses; Bacteria
资金
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Chiesi
- GlaxoSmithKline
- Pfizer
The mechanisms of chronic obstructive pulmonary disease exacerbation are complex. Respiratory viruses (in particular rhinovirus) and bacteria play a major role in the cause of these events. A distinct group of patients seems susceptible to frequent exacerbations, irrespective of disease severity, and this phenotype is stable over time. Many current therapeutic strategies help reduce exacerbation frequency. Further work is required to develop novel anti-inflammatory therapies for exacerbation prevention and treatment. This article focuses on the cause of chronic obstructive pulmonary disease exacerbations, and the current preventative and acute interventions available.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据